Prevalence and risk factors of multidrug-resistant tuberculosis in Jazan, Saudi Arabia

Background Drug-resistant tuberculosis (DR-TB) is a global challenge. Owing to its high annual mortality and morbidity rates, as stated in the annual global TB reports provided by WHO, the prevalence of multidrug-resistant tuberculosis (MDR-TB) or rifampicin-resistant tuberculosis was shown to be in...

Full description

Bibliographic Details
Published in:	Egyptian Journal of Chest Disease and Tuberculosis
Main Authors:	Wael Abdelfattah, Majid A Darraj, Abuobaida K Yassin, Heba M Shalaby
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Subjects:	jazan multidrug-resistant tb mycobacterium tuberculosis rifampicin-resistant tuberculosis
Online Access:	http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=4;spage=547;epage=552;aulast=Abdelfattah

Similar Items

Clinical and Radiological Manifestations of Pulmonary Tuberculosis, Jazan Region, Saudi Arabia
by: Abuobaida Yassin, et al.
Published: (2024-12-01)

Risk factors for positive pulmonary tuberculosis, Jazan Region, Saudi Arabia
by: Abuobaida Yassin
Published: (2024-08-01)

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis
by: Tomasz Bogiel, et al.
Published: (2025-06-01)

Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
by: Betty R. Mchaki, et al.
Published: (2023-02-01)

Evaluation of the Gene Xpert Mycobacterium tuberculosis/resistance to rifampicin assay in rapid diagnosis of tuberculosis and identification of rifampin resistance in tuberculous patients
by: Amal H.G. Hamed, et al.
Published: (2025-01-01)

Knowledge, attitude, and practices of health-care providers toward antibiotic prescribing, antibiotic resistance, and multidrug-resistant tuberculosis
by: Ashna Malhotra, et al.
Published: (2021-01-01)

Factors associated with unfavourable treatment outcomes among patients with Multidrug-resistant Tuberculosis receiving outpatients care
by: Maria Jose Vadakunnel, et al.
Published: (2025-08-01)

Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study
by: Jinsoo Min, et al.
Published: (2025-01-01)

Trends in the incidence of Rifampicin resistant Mycobacterium tuberculosis infection in northeastern Nigeria
by: Muhammad M. Ibrahim, et al.
Published: (2022-09-01)

Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023-01-01)

Diagnostics Evaluation of Smart Sure™ Mycobacterium tuberculosis Screening Kit and Smart Sure™ Multidrug-resistant Tuberculosis Detection Kit on Nonsputum Specimens at a Tertiary Care Center of North India
by: Pankaj Jorwal, et al.
Published: (2024-09-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

GENE MUTATION PATTERNS OF RIFAMPICIN IN MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS COMPLEX STRAINS
by: Esra Yıldırım Servi, et al.
Published: (2022-03-01)

Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
by: John Z. Metcalfe, et al.
Published: (2010-09-01)

Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya
by: Albert Okumu, et al.
Published: (2024-12-01)

Can lipid body-positive rates of Mycobacterium tuberculosis in sputum identify multidrug-resistant or rifampicin-resistant tuberculosis?
by: Tingting Li
Published: (2025-10-01)

Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
by: Yishak Abraham, et al.
Published: (2024-10-01)

Detection of Resistant Prevalent Genes for Mycobacterium Tuberculosis by Line Probe Assay
by: Tejaswini A. Olambe, et al.
Published: (2025-03-01)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
by: Julia Ershova, et al.
Published: (2015-11-01)

Genotypic analysis of multidrug-resistant tuberculosis isolates from extra pulmonary tuberculosis cases in tertiary care centers in Northern India
by: Anand K Maurya, et al.
Published: (2016-01-01)

Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis
by: Sagarika N. Suresh, et al.
Published: (2025-01-01)

Treatment cascade for patients with multidrug- or rifampicin-resistant tuberculosis and associated factors with patient attrition in southeastern China: a retrospective cohort study
by: Bin Chen, et al.
Published: (2023-07-01)

Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone
by: Harriet N. A. Blankson, et al.
Published: (2024-03-01)

Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant <i>Mycobacterium tuberculosis</i> in Zambia
by: Precious Bwalya, et al.
Published: (2021-09-01)

Trends in pediatric tuberculosis diagnosis utilizing xpert Mycobacterium tuberculosis/Rifampicin in a poor-resource, high-burden region: A retrospective, multicenter study
by: Maria Ahuoiza Garba, et al.
Published: (2023-01-01)

Prevalence of multidrug-resistant tuberculosis at a regional drug-resistant tuberculosis center of Maharashtra
by: Gauri Suhas Kulkarni, et al.
Published: (2020-01-01)

CLINICAL CASES OF FOCAL PULMONARY TUBERCULOSIS IN CHILDREN WITH MINIMUM INVOLVEMENT IN MULTIDRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2015-03-01)

Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>
by: Wang Nan，, Yang Yu, Deng Ling, Wu Hui, Liu Zhihui, Meng Fanrong
Published: (2023-12-01)

Predominance of Beijing genotype in extensively drug resistant Mycobacterium tuberculosis isolates from a tertiary care hospital in New Delhi, India
by: Jyoti Arora, et al.
Published: (2013-01-01)

High diversity of multidrug-resistant Mycobacterium tuberculosis Central Asian Strain isolates in Nepal
by: Yogendra Shah, et al.
Published: (2017-10-01)

Tuberculosis prevalence and rifampicin resistance among presumptive patients in Nasarawa State: A three-year retrospective study
by: Ibrahim Hassan Ikrama, et al.
Published: (2024-01-01)

Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting
by: Joas Lucas da Silva, et al.
Published: (2013-02-01)

Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting
by: Joas Lucas da Silva, et al.
Published: (2013-02-01)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
by: Elisabeth Sanchez-Padilla, et al.
Published: (2012-01-01)

Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis
by: Saba Kabir, et al.
Published: (2021-02-01)

Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru
by: Hsien-Ho Lin, et al.
Published: (2012-05-01)

Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique
by: Azar Dokht Khosravi, et al.
Published: (2017-11-01)

Integration of simulation-based medical education: Student satisfaction and self-confidence at Faculty of Medicine, Jazan University, Saudi Arabia
by: Abuobaida Yassin
Published: (2024-12-01)

Discovery of benzo[c]phenanthridine derivatives with potent activity against multidrug-resistant Mycobacterium tuberculosis
by: Yi Chu Liang, et al.
Published: (2024-11-01)